These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 7542352)

  • 1. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
    Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
    Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K; Kotzerke J
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
    Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
    Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
    Fomin DK; Tararukhina OB; Nazarov AA
    Vestn Rentgenol Radiol; 2012; (2):29-31. PubMed ID: 22730757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG; Preston DF; Baxter KG; Dusing RW; Spicer JA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
    Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
    Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
    Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
    Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
    Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
    Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.